DS-omeprazole

download DS-omeprazole

of 2

Transcript of DS-omeprazole

  • 8/8/2019 DS-omeprazole

    1/2

    Cebu Normal UniversityCollege of Nursing

    Osmenia Blvd. Cebu City 6000

    NAS III Pharmacology, Therapeutics and Diagnostics

    DRUG STUDY

    Name of Patient Age Height

    Diagnosis Sex Weight

    Doctor Date of Admission Body Build

    Drug Data Classification Mechanism of Action Indication

    Generic Nameomeprazole

    Trade NameLosec, Prilosec

    Patients Dose

    Minimum Dose

    Maximum Dose

    Contents

    AvailabilityCapsules (delayed-release):10 mg, 20 mg, 40 mg

    Routes of administrationPO

    Pharmacologic Classproton pump inhibitors

    Therapeutic ClassAntiulcer agents

    Pregnancy Risk CategoryC

    Inhibits activity of acid (proton) pump, and binds tohydrogen-potassium adenosine triphosphatase,located at secretory surface of the gastric parietalcells, to block formation of gastric acid.

    Pharmacokinetics

    Onset

    Peak

    Duration

    Drug Half Life

    General Indications

    Symptomatic gastroesophageal reflux disease(GERD) without esophageal lesions

    Erosive esophagitis and accompanyingsymptoms caused by GERD

    Maintenance of healing erosive esophagitis

    Pathologic hypersecretory conditions (such asZollinger-Ellison syndrome)

    Duodenal ulcer (short-term treatment)

    Helicobacter pylori infection and duodenal ulcerdisease, to eradicate H. pylori withclarithromycin (dual therapy)

    H. pylori infection and duodenal ulcer disease,to eradicate H. pylori with clarithromycin andamoxicillin (triple therapy)

    Short-term treatment of active benign gastriculcer

    Patients Actual Indication

    Source: Source: Source: Source:

  • 8/8/2019 DS-omeprazole

    2/2

    Contraindications Adverse Reactions Nursing Responsibilities

    Contraindicated in:Contraindicated in patients hypersensitive todrug or its components.

    PrecautionUse cautiously with pregnancy, lactation

    Drug interactionDrug-drug.

    Ampicillin esters, iron derivatives,ketoconazole: may exhibit poor bioavailabilityin patients taking omeprazole becauseoptimal absorption of these drugs needs alow gastric pH. Avoid using together.Diazepam, phenytoin, warfarin: decreaseshepatic clearance, possibly leading toincreased serum levels. Monitor closely.Drug-herb.Male fern: male fern is inactivated in alkalineenvironments. Patient should separateadministration.

    Pennyroyal: may change rate of formation oftoxic metabolites of pennyroyal. Avoid usingtogether.

    CNS: headache, dizziness, asthenia

    GI: diarrhea, abdominal pain, nausea, vomiting,constipation, flatulence

    Musculoskeletal: back pain

    Respiratory: cough, upper respiratory tract infection

    Skin: rash

    Before

    Assess patients history: Hypersensitivity to omeprazole orany of its components; pregnancy, lactation

    Conduct physical assessment: Skin lesions; T; reflexes,affect; urinary output, abdominal exam; respiratoryauscultation

    Dosage adjustments aren't needed for patients with renalor hepatic impairment.

    Omeprazole increases its own bioavailability with repeateddosages. Drug is labile in gastric acid; less drug is lost tohydrolysis because drug increases gastric pH.

    Don't confuse Prilosec with Prozac, Prilocaine, or Prinivil.During

    Tell patient to swallow capsules whole and not to open,crush, or chew them.

    Administer drug 30 minutes before meals.

    Administer antacids with omeprazole, if needed.

    After

    Caution patient not to perform hazardous activities ifdizziness occurs

    Arrange for further evaluation of patient after 8 wks oftherapy for gastroreflux disorders; not intended formaintenance therapy.

    Instruct patient to have regular medical follow-up visits.

    Inform patient of the possible side effects of drug andadvise to consult with your health care provider ifuncomfortable

    Advise patient to report severe headache, worsening ofsymptoms, fever, and chills.

    Source: Source: Source: